Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib

Affiliations

• ¹ Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
• ² Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, China.
• ³ Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
• ⁴ Department of Oncology, Nantong Tumor Hospital, Nantong 226361, China.
• ⁵ Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
• ⁶ Department of Respiratory Medicine, Jinling Hospital, Nanjing 210002, China.